Theseus Pharmaceuticals Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	4,511,446	4,910,828	4,506,392	4,723,415	6,750,873	-716,719	Upgrade
Depreciation & Amortization	15,586,785	15,355,439	14,442,451	13,582,969	10,057,861	9,871,768	Upgrade
Other Amortization	203,009	203,009	178,712	120,189	146,162	139,647	Upgrade
Other Operating Activities	-1,280,913	-1,373,190	-1,447,070	-2,749,742	-5,982,985	1,753,205	Upgrade
Operating Cash Flow	19,020,327	19,096,086	17,680,485	15,676,831	10,971,911	11,047,901	Upgrade
Operating Cash Flow Growth	0.90%	8.01%	12.78%	42.88%	-0.69%	4.34%	Upgrade
Capital Expenditures	-15,815,696	-12,516,425	-11,759,661	-10,350,352	-9,395,238	-7,351,586	Upgrade
Sale of Property, Plant & Equipment	101,057	113,492	93,943	-	13,990	44,806	Upgrade
Cash Acquisitions	-	-	-	3,575,874	-	-	Upgrade
Divestitures	-	-	-	2,702,688	-11,096	-	Upgrade
Sale (Purchase) of Intangibles	-122,825	-156,178	789,668	-78,684	7,920,123	-278,877	Upgrade
Investment in Securities	103,379	70,143	82,964	-101,415	221,393	571,680	Upgrade
Other Investing Activities	24,164	24,164	21,897	239,455	41,671	51,174	Upgrade
Investing Cash Flow	-15,709,921	-12,464,804	-10,771,189	-4,012,434	-1,209,157	-6,962,803	Upgrade
Short-Term Debt Issued	-	-	-	-	400,000	-	Upgrade
Long-Term Debt Issued	-	2,620,000	2,498,904	14,730,000	6,492,280	520,800	Upgrade
Total Debt Issued	8,100,000	2,620,000	2,498,904	14,730,000	6,892,280	520,800	Upgrade
Short-Term Debt Repaid	-	-	-	-1,060,000	-	-	Upgrade
Long-Term Debt Repaid	-	-7,599,071	-11,640,909	-17,783,888	-5,118,982	-8,676,064	Upgrade
Total Debt Repaid	-10,625,996	-7,599,071	-11,640,909	-18,843,888	-5,118,982	-8,676,064	Upgrade
Net Debt Issued (Repaid)	-2,525,996	-4,979,071	-9,142,005	-4,113,888	1,773,298	-8,155,264	Upgrade
Issuance of Common Stock	-	247	-	-	-	-	Upgrade
Repurchase of Common Stock	-	-	-	-123	-	-	Upgrade
Common Dividends Paid	-2	-2,163,841	-2,061,404	-2,000,022	-9,498,715	-	Upgrade
Other Financing Activities	-146,878	-237,716	92,387	-40,572	-39,170	-22,226	Upgrade
Financing Cash Flow	-2,672,876	-7,380,381	-11,111,022	-6,154,605	-7,764,587	-8,177,490	Upgrade
Foreign Exchange Rate Adjustments	-32,788	13,624	-116,581	209,082	8,593	-6,536	Upgrade
Net Cash Flow	604,742	-735,475	-4,318,307	5,718,874	2,006,760	-4,098,928	Upgrade
Free Cash Flow	3,204,631	6,579,661	5,920,824	5,326,479	1,576,673	3,696,315	Upgrade
Free Cash Flow Growth	-52.42%	11.13%	11.16%	237.83%	-57.34%	58543.74%	Upgrade
Free Cash Flow Margin	5.82%	11.77%	11.56%	11.39%	5.02%	13.24%	Upgrade
Free Cash Flow Per Share	-	204.01	183.59	165.60	72.54	170.06	Upgrade
Cash Interest Paid	4,450,659	4,450,659	5,071,923	3,855,508	2,778,641	2,371,742	Upgrade
Cash Income Tax Paid	1,693,706	1,693,706	1,020,363	36,742	102,925	-349,006	Upgrade
Levered Free Cash Flow	2,047,548	2,681,170	5,594,961	9,350,100	9,341,676	3,537,414	Upgrade
Unlevered Free Cash Flow	4,813,609	5,473,046	8,543,908	12,061,075	11,208,275	5,432,605	Upgrade
Change in Net Working Capital	1,312,332	4,180,093	936,551	-5,124,430	-7,615	-2,154,842	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.